Advertisement
UK markets closed
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.35
    +1.45 (+1.77%)
     
  • GOLD FUTURES

    2,336.50
    -9.90 (-0.42%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • Bitcoin GBP

    53,240.27
    -195.12 (-0.37%)
     
  • CMC Crypto 200

    1,422.05
    +7.29 (+0.51%)
     
  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Hikma Pharma to meet investors for potential dollar bond -leads

DUBAI, March 25 (Reuters) - Hikma Pharmaceuticals Plc (LSE: HIK.L - news) , a drugs group founded in Jordan in 1978, has picked four banks to arrange a series of fixed income meetings starting Friday for a potential benchmark dollar bond, a document from lead arrangers showed.

The company has picked Citigroup (NYSE: C - news) , Barclays (LSE: BARC.L - news) , HSBC and National Bank (NYSE: NBHC - news) of Abu Dhabi to arrange investor meetings in Europe and the Middle East, the document stated.

Hikma, rated BB+ Standard (Other OTC: SNDH - news) and Poor's and Ba1 by Moody's, joined Britain's benchmark FTSE 100 equity index in March. Getting into the FTSE 100 can often fuel further demand for a company's shares, since funds that track the FTSE or invest in the index can then add that stock to their portfolio. (Reporting by Archana Narayanan; editing by Matt Smith)